STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,960,000 | +14.2% | 276,656 | +15.6% | 0.00% | – |
| Q3 2016 | $2,591,000 | +104.2% | 239,232 | +27.6% | 0.00% | – |
| Q2 2016 | $1,269,000 | +54.6% | 187,428 | +6.4% | 0.00% | – |
| Q1 2016 | $821,000 | -32.8% | 176,136 | -9.0% | 0.00% | – |
| Q4 2015 | $1,222,000 | -21.5% | 193,656 | +9.8% | 0.00% | – |
| Q3 2015 | $1,557,000 | +2.6% | 176,296 | +36.7% | 0.00% | – |
| Q2 2015 | $1,518,000 | -25.1% | 128,952 | -7.9% | 0.00% | – |
| Q1 2015 | $2,026,000 | +14.6% | 140,007 | +35.1% | 0.00% | – |
| Q4 2014 | $1,768,000 | +32.9% | 103,631 | -2.9% | 0.00% | – |
| Q3 2014 | $1,330,000 | -27.7% | 106,742 | -14.8% | 0.00% | – |
| Q2 2014 | $1,839,000 | -22.0% | 125,346 | +8.2% | 0.00% | – |
| Q1 2014 | $2,358,000 | +5.7% | 115,823 | +1.8% | 0.00% | – |
| Q4 2013 | $2,231,000 | -55.2% | 113,823 | +3.5% | 0.00% | -100.0% |
| Q3 2013 | $4,980,000 | +110.4% | 109,938 | +10.7% | 0.00% | – |
| Q2 2013 | $2,367,000 | – | 99,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |